RMFCX
Price
$56.85
Change
+$0.01 (+0.02%)
Updated
Jan 24 closing price
Net Assets
105.35B
THCVX
Price
$26.83
Change
-$0.02 (-0.07%)
Updated
Jan 24 closing price
Net Assets
10.97B
Ad is loading...

RMFCX vs THCVX

Header iconRMFCX vs THCVX Comparison
Open Charts RMFCX vs THCVXBanner chart's image
American Funds American Mutual R3
Price$56.85
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets105.35B
Nuveen Large Cap Value Idx I
Price$26.83
Change-$0.02 (-0.07%)
VolumeN/A
Net Assets10.97B
RMFCX vs THCVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. THCVX commentary
Jan 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and THCVX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. THCVX (11B). THCVX pays higher dividends than RMFCX: THCVX (2.02) vs RMFCX (1.69). RMFCX was incepted earlier than THCVX: RMFCX (23 years) vs THCVX (9 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. THCVX (21.00). THCVX has a lower initial minimum investment than RMFCX: THCVX (0) vs RMFCX (250). THCVX annual gain was more profitable for investors over the last year : 18.06 vs. RMFCX (13.15). THCVX (43.58) and RMFCX (41.65) have equivalent 5 years return.
RMFCXTHCVXRMFCX / THCVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD4.1404.76487%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets105B11B955%
Annual Yield % from dividends1.692.0284%
Returns for 1 year13.1518.0673%
Returns for 3 years17.6718.9193%
Returns for 5 years41.6543.5896%
Returns for 10 years68.02N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBSW3.760.10
+2.73%
Sibanye-Stillwater
NERV2.16N/A
N/A
Minerva Neurosciences
EVRI13.62-0.02
-0.15%
Everi Holdings
SMMT23.76-0.89
-3.61%
Summit Therapeutics
CDZI4.53-0.35
-7.16%
CADIZ